AU2021901241A0 - Thermally stable vaccine formulations - Google Patents

Thermally stable vaccine formulations

Info

Publication number
AU2021901241A0
AU2021901241A0 AU2021901241A AU2021901241A AU2021901241A0 AU 2021901241 A0 AU2021901241 A0 AU 2021901241A0 AU 2021901241 A AU2021901241 A AU 2021901241A AU 2021901241 A AU2021901241 A AU 2021901241A AU 2021901241 A0 AU2021901241 A0 AU 2021901241A0
Authority
AU
Australia
Prior art keywords
thermally stable
vaccine formulations
stable vaccine
formulations
thermally
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
AU2021901241A
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Commonwealth Scientific and Industrial Research Organization CSIRO
Original Assignee
Commonwealth Scientific and Industrial Research Organization CSIRO
Filing date
Publication date
Application filed by Commonwealth Scientific and Industrial Research Organization CSIRO filed Critical Commonwealth Scientific and Industrial Research Organization CSIRO
Publication of AU2021901241A0 publication Critical patent/AU2021901241A0/en
Priority to AU2022265735A priority Critical patent/AU2022265735A1/en
Priority to EP22794101.0A priority patent/EP4329814A1/en
Priority to US18/285,814 priority patent/US20240180843A1/en
Priority to PCT/AU2022/050390 priority patent/WO2022226594A1/en
Pending legal-status Critical Current

Links

AU2021901241A 2021-04-27 2021-04-27 Thermally stable vaccine formulations Pending AU2021901241A0 (en)

Priority Applications (4)

Application Number Priority Date Filing Date Title
AU2022265735A AU2022265735A1 (en) 2021-04-27 2022-04-27 Thermally stable vaccine formulations utilising metal organic framework (mof) shells
EP22794101.0A EP4329814A1 (en) 2021-04-27 2022-04-27 Thermally stable vaccine formulations utilising metal organic framework (mof) shells
US18/285,814 US20240180843A1 (en) 2021-04-27 2022-04-27 Thermally Stable Vaccine Formulations Utilising Metal Organic Framework (MOF) Shells
PCT/AU2022/050390 WO2022226594A1 (en) 2021-04-27 2022-04-27 Thermally stable vaccine formulations utilising metal organic framework (mof) shells

Publications (1)

Publication Number Publication Date
AU2021901241A0 true AU2021901241A0 (en) 2021-05-13

Family

ID=

Similar Documents

Publication Publication Date Title
EP4135765A4 (en) Pan-coronavirus vaccine compositions
EP4097123A4 (en) Coronavirus vaccine formulations
EP4045480A4 (en) Pharmaceutical formulations
EP3773721A4 (en) Stable anti-cd79b immunoconjugate formulations
EP3823666A4 (en) Vaccine formulations comprising preservative system
EP3600396A4 (en) Nucleic acid vaccine composition comprising a lipid formulation, and method of increasing the potency of nucleic acid vaccines
EP3955910A4 (en) Sustained release formulations
EP4072553A4 (en) Cariprazine release formulations
EP3746078A4 (en) Oral formulations and uses thereof
IL306088A (en) Coronavirus vaccine formulations
EP3796915A4 (en) Oral formulations comprising rivaroxaban
EP4007590A4 (en) Formulations including dihydrohonokiol
EP3908316A4 (en) Tlr4-tlr7 ligand formulations as vaccine adjuvants
AU2021901241A0 (en) Thermally stable vaccine formulations
AU2021901467A0 (en) Thermally stable formulations
EP3923981A4 (en) Vaccine adjuvants and formulations
EP4013441A4 (en) Larazotide formulations
GB202009684D0 (en) Formulations
EP3585397A4 (en) Solid oral formulations of amphotericin b
EP3801532A4 (en) Formulations of raltegravir
AU2020903704A0 (en) Immunogenic formulations
AU2021298249B2 (en) Formulations
EP3389786A4 (en) Thermally stable rotavirus vaccine formulations and methods of use thereof
AU2020903873A0 (en) Lymph-Targeting Formulations
AU2020901866A0 (en) Immugenic formulations